Journal of Antimicrobial Chemotherapy (1999) 44, 705-708
© 1999 The British Society for Antimicrobial Chemotherapy
Brief report |
Cytopathic effect inhibition assay for determining the in-vitro susceptibility of herpes simplex virus to antiviral agents
a Servicio de Microbiología Clínica y Enfermedades Infecciosas-VIH, Hospital General Universitario Gregorio Marañón', Madrid 28007; b Centro Nacional de Microbiología, Virología e Inmunología Sanitarias, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
We compare a rapid dilution method for the determination of antiviral susceptibility of herpes simplex virus (HSV) with the plaque reduction assay. A total of 84 HSV clinical isolates were studied by both methods to detect in-vitro resistance to acyclovir and foscarnet. The rapid method showed for the detection of HSV isolates resistant to acyclovir and foscarnet, a sensitivity of 96.8% and 100% and specificity of 100% and 100%, respectively. This method provides an easy and accurate screening procedure for the susceptibility testing of HSV to antiviral agents.
* Corresponding author. Tel:+34-1-586-84-53; Fax:+34-1-504-49-06; E-mail: micro{at}micro.hggm.es
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. Stranska, A. M. van Loon, M. Polman, and R. Schuurman Application of Real-Time PCR for Determination of Antiviral Drug Susceptibility of Herpes Simplex Virus Antimicrob. Agents Chemother., September 1, 2002; 46(9): 2943 - 2947. [Abstract] [Full Text] [PDF] |
||||
